Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

SR Space failed to raise the planned ₽1.53 billion

10/4/24 OTCI

Promsvyazbank set the buyout price for CarMoney shares

10/4/24 CARM

Renaissance Insurance bought Raiffeisen Life

10/4/24 RENI

Fesco will remain the single logistics operator of the Vostochny terminal

10/3/24 FESH

Sollers' sales in January - September grew by 18%

10/3/24 SVAV

Mosgorlombard's revenue grew 4.5 times in January-September

10/3/24 MGKL

Yandex wants to enter the insurance market

10/3/24 YDEX

Non-residents put less than 1% of MTS shares on offer

10/3/24 MTSS

Moscow Exchange summarized the results of trading in September

10/2/24 MOEX

Rosdorbank launched road factoring

10/2/24 RDRB